Clinical Trial Update: A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice

View source ↗

Summary

A completed clinical trial evaluating symptom improvement after an induction dose of ustekinumab for ulcerative colitis in Japanese practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Ulcerative Colitis | Status: COMPLETED